Evidence map›Paper›PMID 35854310›Full record

ArticleImplementation science : IS2022

Effect of a tailored sepsis treatment protocol on patient outcomes in the Tikur Anbessa Specialized Hospital, Ethiopia: results of an interrupted time series analysis.

Lisa M Puchalski Ritchie, Lemlem Beza, Finot Debebe, Andualem Wubetie, Kathleen Gamble, Gerald Lebovic, Sharon E Straus, Tigist Zewdu, Aklilu Azazh, Cheryl Hunchak and 2 more

Abstract read
In one paragraph

Article in Implementation science : IS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lisa M Puchalski RitchieDepartment of Medicine, University of Toronto, Toronto, Canada. lisa.puchalskiritchie@utoronto.ca.ORCID 0000-0002-1791-5368
Lemlem BezaDepartment of Emergency Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Finot DebebeDepartment of Emergency Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Andualem WubetieDepartment of Emergency Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Kathleen GambleLi Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada.
Gerald LebovicLi Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada.
Sharon E StrausDepartment of Medicine, University of Toronto, Toronto, Canada.
Tigist ZewduDepartment of Emergency Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Aklilu AzazhDepartment of Emergency Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Cheryl HunchakDivision of Emergency Medicine, Department of Family and Community Medicine, University of Toronto, Toronto, Canada.
Megan LandesDepartment of Emergency Medicine, University Health Network, Toronto, Canada.
Dawit Kebebe HulukaDepartment of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

CIHR KAL-139700
6 · The paper itself

Abstract

backgroundDespite improvement, sepsis mortality rates remain high, with an estimated 11 million sepsis-related deaths globally in 2017 (Rudd et. al, Lancet 395:200-211, 2020). Low- and middle-income countries (LMICs) are estimated to account for 85% of global sepsis mortality; however, evidence for improved sepsis mortality in LMICs is lacking. We aimed to improve sepsis care and outcomes through development and evaluation of a sepsis treatment protocol tailored to the Tikur Anbessa Specialized Hospital Emergency Department, Ethiopia, context.

methodsWe employed a mixed methods design, including an interrupted times series study, pre-post knowledge testing, and process evaluation. The primary outcome was the proportion of patients receiving appropriate sepsis care (blood culture collection before antibiotics and initiation of appropriate antibiotics within 1 h of assessment). Secondary outcomes included time to antibiotic administration, 72-h sepsis mortality, and 90-day all-cause mortality. Due to poor documentation, we were unable to assess our primary outcome and time to antibiotic administration. We used segmented regression with outcomes as binomial proportions to assess the impact of the intervention on mortality. Pre-post knowledge test scores were analyzed using the Student's t-test to compare group means for percentage of scenarios with correct diagnosis.

resultsA total of 113 and 300 patients were enrolled in the pre-implementation and post-implementation phases respectively. While age and gender were similar across the phases, a higher proportion (31 vs. 57%) of patients had malignancies in the post-implementation phase. We found a significant change in trend between the phases, with a trend for increasing odds of survival in the pre-implementation phase (OR 1.24, 95% CI 0.98-1.56), and a shift down, with odds of survival virtually flat (OR 0.95, 95% CI. 0.88-1.03) in the post-implementation phases for 72-h mortality, and trends for survival pre- and post-implementation are virtually flat for 90-day mortality. We found no significant difference in pre-post knowledge test scores, with interpretation limited by response rate. Implementation quality was negatively impacted by resource challenges.

conclusionWe found no improvement in sepsis outcomes, with a trend for increasing odds of survival lost post-implementation and no significant change in knowledge pre- and post-implementation. Variable availability of resources was the principal barrier to implementation.

trial registrationOpen Science Framework osf.io/ju4ga . Registered June 28, 2017.

Indexed as

SepsisAnti-Bacterial AgentsClinical ProtocolsEthiopiaHospitalsHumansInterrupted Time Series AnalysisAnti-Bacterial AgentsAfricaEthiopiaInterrupted time seriesSepsisTreatment protocol

Identifiers

PMID35854310
PMCPMC9295292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.